MXPA04000980A - Tratamiento de hipertension ocular y glaucoma. - Google Patents
Tratamiento de hipertension ocular y glaucoma.Info
- Publication number
- MXPA04000980A MXPA04000980A MXPA04000980A MXPA04000980A MXPA04000980A MX PA04000980 A MXPA04000980 A MX PA04000980A MX PA04000980 A MXPA04000980 A MX PA04000980A MX PA04000980 A MXPA04000980 A MX PA04000980A MX PA04000980 A MXPA04000980 A MX PA04000980A
- Authority
- MX
- Mexico
- Prior art keywords
- treatment
- glaucoma
- ocular hypertension
- micrograms
- keto
- Prior art date
Links
- 208000010412 Glaucoma Diseases 0.000 title abstract 2
- 206010030043 Ocular hypertension Diseases 0.000 title abstract 2
- 230000000694 effects Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US30858901P | 2001-07-31 | 2001-07-31 | |
| PCT/JP2002/007699 WO2003011299A2 (en) | 2001-07-31 | 2002-07-30 | Treatment of ocular hypertension and glaucoma |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA04000980A true MXPA04000980A (es) | 2004-04-20 |
Family
ID=23194562
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA04000980A MXPA04000980A (es) | 2001-07-31 | 2002-07-30 | Tratamiento de hipertension ocular y glaucoma. |
Country Status (8)
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2005519978A (ja) * | 2002-03-28 | 2005-07-07 | スキャンポ・アーゲー | 高眼圧症および緑内障の処置方法 |
| AR043161A1 (es) * | 2003-02-14 | 2005-07-20 | Sucampo Pharmaceuticals Inc | Composicion oftalmica para tratar hipertension ocular y glaucoma |
| WO2008008701A2 (en) * | 2006-07-10 | 2008-01-17 | Allergan, Inc. | Substituted cyclopentane derivatives as therapeutic agents |
| WO2008008718A2 (en) * | 2006-07-11 | 2008-01-17 | Allergan, Inc. | Cyclopentane derivatives as antiglaucoma agents |
| US20080015219A1 (en) * | 2006-07-11 | 2008-01-17 | Allergan, Inc. | Therapeutic compounds |
| NZ582705A (en) * | 2007-07-03 | 2012-06-29 | Allergan Inc | Therapeutic substituted cyclopentanes for reducing intraocular pressure |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE162074T1 (de) * | 1988-10-01 | 1998-01-15 | R Tech Ueno Ltd | Oculare hypotensive mittel |
| BR0109192A (pt) * | 2000-03-16 | 2003-05-27 | Sucampo Ag | Tratamento de hipertensão ocular e glaucoma. |
| US20020035148A1 (en) * | 2000-07-20 | 2002-03-21 | Ryuji Ueno | Treatment of ocular hypertension |
-
2002
- 2002-07-30 EP EP02751774A patent/EP1411950A2/en not_active Withdrawn
- 2002-07-30 MX MXPA04000980A patent/MXPA04000980A/es unknown
- 2002-07-30 WO PCT/JP2002/007699 patent/WO2003011299A2/en not_active Application Discontinuation
- 2002-07-30 JP JP2003516529A patent/JP2004538306A/ja not_active Withdrawn
- 2002-07-30 CA CA002454422A patent/CA2454422A1/en not_active Abandoned
- 2002-07-30 KR KR10-2004-7001587A patent/KR20040023707A/ko not_active Withdrawn
- 2002-07-30 CN CNA028190947A patent/CN1646134A/zh active Pending
- 2002-07-30 BR BR0211545-0A patent/BR0211545A/pt not_active Application Discontinuation
- 2002-07-31 WO PCT/US2002/024072 patent/WO2003011178A2/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2454422A1 (en) | 2003-02-13 |
| CN1646134A (zh) | 2005-07-27 |
| KR20040023707A (ko) | 2004-03-18 |
| WO2003011299A2 (en) | 2003-02-13 |
| JP2004538306A (ja) | 2004-12-24 |
| EP1411950A2 (en) | 2004-04-28 |
| WO2003011299A3 (en) | 2003-10-30 |
| BR0211545A (pt) | 2004-07-13 |
| WO2003011178A2 (en) | 2003-02-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2502437A1 (en) | Method and composition containing latanoprost for treating ocular hypertension and glaucoma | |
| TWI255714B (en) | Method for treating meibomian gland disease | |
| MX9702349A (es) | Usos de derivado de 9-deoxi prostaglandina para tratar glaucoma. | |
| BR9808016A (pt) | Composições e métodos para redução da hipertensão ocular | |
| MXPA03010146A (es) | Composiciones de lipidos hipotensivos (derivados de prostaglandina) y timolol, y metodos para usar las mismas. | |
| AU3056702A (en) | Methods and compositions for treatment of ocular neovascularization and neural injury | |
| CA2440764A1 (en) | Combination of brimonidine and timolol for topical ophthalmic use | |
| PT868186E (pt) | Utilizacao de certos compostos de isoquinolinossulfonilo para tratamento de glaucoma e isquemia ocular | |
| CA2198245A1 (en) | Methods and means for drug administration | |
| WO2003092584A3 (en) | Agents which regulate, inhibit, or modulate the activity and/or expression of connective tissue growth factor (ctgf) as a unique means to both lower intraocular pressure and treat glaucomatous retinopathies/optic neuropathies | |
| KR101820184B1 (ko) | 방부제가 없는 비마토프로스트 및 티몰롤 용액 | |
| WO2000018316A3 (en) | Sustained release, and comfortable ophthalmic composition and method for ocular therapy | |
| WO2002009702A3 (en) | Use of indole derivatives for the manufacture of a medicament for reducing intracular pressure | |
| WO2001030380A3 (en) | Methods and compositions for treatment of keratoconus using protease inhibitors | |
| AU5446299A (en) | Medicinal compositions for treating eye diseases | |
| WO1998039293A3 (en) | 13-thia prostaglandins for use in glaucoma therapy | |
| WO1999043309A3 (en) | Anticonvulsant drugs and pharmaceutical compositions thereof | |
| CA2171226A1 (en) | Treatment of optic nerve disorder with prostanoic acid compounds | |
| ATE223200T1 (de) | Einen carboanhydrase-hemmer und xanthangummi enthaltendes augenarzneimittel | |
| MXPA04000980A (es) | Tratamiento de hipertension ocular y glaucoma. | |
| DK1187611T3 (da) | Oftalmiske histaminholdige sammensætninger og anvendelse deraf | |
| AU609807B2 (en) | A composition for the topical treatment of glaucoma or ocular hypertension | |
| WO2002072105A3 (en) | Improved prostanoid therapies for the treatment of glaucoma | |
| CA2414586A1 (en) | Agent for therapeutic treatment of optic nerve diseases and the like | |
| JP5041761B2 (ja) | 眼粘膜適用製剤 |